Upadacitinib for orofacial granulomatosis associated with Crohn's disease
Journal of the European Academy of Dermatology and Venereology · 2025-05 · 39 (5)
DOI: 10.1111/jdv.20486 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 07.12.2024. Verfasst von Gaëlle Colin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
- Department of Gastroenterology, Montpellier University Hospital and Montpellier University, Montpellier, France.
ORCID-Profile: Gaëlle Colin
Zitieren
APA
Colin, G., Girod, M., Malezieux, E., Altwegg, R., & Girard, C. (2025). Upadacitinib for orofacial granulomatosis associated with Crohn's disease. Journal of the European Academy of Dermatology and Venereology, 39(5). https://doi.org/10.1111/jdv.20486
Vancouver
Colin G, Girod M, Malezieux E, Altwegg R, Girard C. Upadacitinib for orofacial granulomatosis associated with Crohn's disease. Journal of the European Academy of Dermatology and Venereology. 2025;39(5). doi:10.1111/jdv.20486
BibTeX
@article{Colin2025,
author = {Colin, Gaëlle and Girod, Manon and Malezieux, Emilie and Altwegg, Romain and Girard, Céline},
title = {Upadacitinib for orofacial granulomatosis associated with Crohn's disease},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {5},
doi = {10.1111/jdv.20486}
}
EUVIMED